ChromaDex Corporation - stock earnings
CDXC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 114000 USD | 21.2 million USD |
| 2023Q3 | -959000 USD | 19.5 million USD |
| 2023Q2 | -2.2 million USD | 20.3 million USD |
| 2023Q1 | -1.3 million USD | 22.6 million USD |
| 2022Q4 | 673000 USD | 21.0 million USD |
| 2022Q3 | 1.1 million USD | 17.1 million USD |
| 2022Q2 | -6.4 million USD | 16.7 million USD |
| 2022Q1 | -7.7 million USD | 17.3 million USD |
| 2021Q4 | -5.3 million USD | 17.8 million USD |
| 2021Q3 | -8.9 million USD | 17.3 million USD |
| 2021Q2 | -5.6 million USD | 17.7 million USD |
| 2021Q1 | -7.4 million USD | 14.7 million USD |
| 2020Q4 | -6.1 million USD | 15.4 million USD |
| 2020Q3 | -4.2 million USD | 14.2 million USD |
| 2020Q2 | -3.7 million USD | 15.3 million USD |
| 2020Q1 | -5.9 million USD | 14.3 million USD |
| 2019Q4 | -8.9 million USD | 13.1 million USD |
| 2019Q3 | -7.2 million USD | 12.1 million USD |
| 2019Q2 | -7.8 million USD | 11.1 million USD |
| 2019Q1 | -8.3 million USD | 10.0 million USD |
| 2018Q4 | -8.2 million USD | 9.1 million USD |
| 2018Q3 | -8.6 million USD | 8.1 million USD |
| 2018Q2 | -8.1 million USD | 7.8 million USD |
| 2018Q1 | -8.4 million USD | 6.6 million USD |
| 2017Q4 | -8.8 million USD | 7.5 million USD |
| 2017Q3 | 2.1 million USD | 6.1 million USD |
| 2017Q2 | -2.8 million USD | 5.3 million USD |
| 2017Q1 | -1.9 million USD | 4.4 million USD |
| 2016Q4 | -2.1 million USD | 5.6 million USD |
| 2016Q3 | -954390 USD | 5.0 million USD |
| 2016Q2 | -82667 USD | 8.8 million USD |
| 2016Q1 | 255625 USD | 7.3 million USD |
| 2015Q4 | -1.4 million USD | 4.4 million USD |
| 2015Q3 | -3716 USD | 6.3 million USD |
| 2015Q2 | -315192 USD | 6.1 million USD |
| 2015Q1 | -1.0 million USD | 5.3 million USD |
| 2014Q4 | -1.2 million USD | 4.2 million USD |
| 2014Q3 | -659653 USD | 4.1 million USD |
| 2014Q2 | -1.7 million USD | 3.9 million USD |
| 2014Q1 | -1.8 million USD | 3.1 million USD |
| 2013Q4 | -724324 USD | 2.4 million USD |
| 2013Q3 | -1.3 million USD | 2.7 million USD |
| 2013Q2 | -989722 USD | 2.7 million USD |
| 2013Q1 | 1.5 million USD | 2.3 million USD |
| 2012Q4 | -1.7 million USD | 3.5 million USD |
| 2012Q3 | -1.5 million USD | 3.6 million USD |
| 2012Q2 | -4.0 million USD | 2.7 million USD |
| 2012Q1 | -4.4 million USD | 1.8 million USD |
| 2011Q4 | -2.5 million USD | 1.8 million USD |
| 2011Q3 | -2.4 million USD | 1.8 million USD |
| 2011Q2 | -1.8 million USD | 1.9 million USD |
| 2011Q1 | -1.2 million USD | 2.5 million USD |
| 2010Q4 | -898666 USD | 2.0 million USD |
| 2010Q3 | -883223 USD | 1.6 million USD |
| 2010Q2 | -303529 USD | 2.0 million USD |
| 2010Q1 | 33742 USD | 1.9 million USD |
| 2009Q4 | -115081 USD | 1.6 million USD |
| 2009Q3 | -177544 USD | 1.4 million USD |
| 2009Q2 | -291100 USD | 1.3 million USD |
| 2009Q1 | -649547 USD | 1.2 million USD |
| 2008Q4 | -649547 USD | 1.2 million USD |
| 2008Q3 | -710347 USD | 1.1 million USD |
| 2008Q2 | -621676 USD | 1.2 million USD |
| 2008Q1 | -2928 USD | 1.1 million USD |
| 2007Q4 | -3545 USD | 1.4 million USD |
| 2007Q3 | -4302 USD | 1.2 million USD |
| 2007Q2 | -2910 USD | 1.0 million USD |
| 2007Q1 | -27625 USD | ? USD |
| 2006Q4 | -27625 USD | ? USD |
CDXC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -4.9 million USD | 83.6 million USD |
| 2022 | -14.4 million USD | 72.1 million USD |
| 2021 | -25.6 million USD | 67.4 million USD |
| 2020 | -18.5 million USD | 59.3 million USD |
| 2019 | -31.5 million USD | 46.3 million USD |
| 2018 | -33.3 million USD | 31.6 million USD |
| 2017 | -11.4 million USD | 21.2 million USD |
| 2016 | -2.9 million USD | 26.8 million USD |
| 2015 | -2.8 million USD | 22.0 million USD |
| 2014 | -5.4 million USD | 15.3 million USD |
| 2013 | -4.4 million USD | 10.2 million USD |
| 2012 | -11.7 million USD | 11.6 million USD |
| 2011 | -7.9 million USD | 8.1 million USD |
| 2010 | -2.1 million USD | 7.6 million USD |
| 2009 | -907568 USD | 5.8 million USD |
| 2008 | -2.1 million USD | 4.5 million USD |
| 2007 | -38382 USD | 4.8 million USD |
CDXC
Price: $3.78
52 week price:
Earnings Per Share: -0.07 USD
P/E Ratio: -16.89
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 333600
Ebitda: -3.0 millionMarket Capitalization: 299.7 million